Reneo Pharmaceuticals (RPHM) Revenue & Revenue Breakdown
Reneo Pharmaceuticals Revenue Highlights
00
Reneo Pharmaceuticals Revenue by Period
Reneo Pharmaceuticals Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | - |
Reneo Pharmaceuticals Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $734.00K | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | - |
Reneo Pharmaceuticals Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
RPRX | Royalty Pharma | $2.35B | $564.69M |
APLS | Apellis Pharmaceuticals | $366.28M | $176.57M |
LEGN | Legend Biotech | $285.14M | $93.99M |
DNA | Ginkgo Bioworks | $251.46M | $89.05M |
ADPT | Adaptive Bio | $170.28M | $46.44M |
VIR | Vir Bio | $86.18M | $2.38M |
HOWL | Werewolf Therapeutics | $19.94M | $1.14M |
KZR | Kezar Life Sciences | $7.00M | - |
KRON | Kronos Bio | $6.29M | $2.37M |
CGEM | Cullinan Oncology | - | - |
CCCC | C4 Therapeutics | - | - |
AVRO | AVROBIO | - | - |
CNSP | CNS Pharmaceuticals | - | - |
NKTX | Nkarta | - | - |
PRME | Prime Medicine | - | $39.31M |
DBTX | Decibel Therapeutics | - | - |
SMMT | Summit Therapeutics | - | - |
CELC | Celcuity | - | - |
OCEA | Ocean Biomedical | - | - |
IMMX | Immix Biopharma | - | - |
EWTX | Edgewise Therapeutics | - | - |
HEPA | Hepion Pharmaceuticals | - | - |
RPHM | Reneo Pharmaceuticals | - | - |